GIOSTAR MOU for World’s First Stem Cell University & Hospital Campus with Amravati, State of Andhra Pradesh
GIOSTAR MOU for World’s First Stem Cell University & Hospital Campus with Amravati, State of Andhra Pradesh, INDIA
My name is Bharat Bhai Shah and I am 67 years old. I was suffering from recurrent ulcerations that used to get relieved with topical applications of antibiotics; only to happen again! I had a constant pain around those patches of my cheek, but ignored it for quite some time. Almost 2-3 months ago, I had been for my dental checks; where I was warned for the doubtful ulceration around my left cheek! As I was tired of repeated ulcerations and pain in my mouth; I decided to have a detailed consultation with the specialist at GIOSTAR.
I found the staff and experts very knowledgeable, humble and friendly. I had consultation with an expert and was advised to undergo biopsy check on 4th July; which turned out to be a buccal mucosa. As a matter of fact, I had been offered three sessions of Cancer Immunotherapy, with an interval of 15 days; after each infusion.
Accordingly, the first session of treatment was scheduled on 29th July. It was just a one day matter and I was discharged on the same day. Initially I was worried about the treatment outcome and effectiveness, as I felt pain around my teeth after first session of infusion. I experienced almost 50% pain reduction after second round of infusion and this definitely strengthened my confidence. I was feeling improvement internally. I strictly followed my diet chart. I did not experience any sort of problem, such as loss of appetite, loss of weight.
After my third session i.e. on 26th August, I am living completely painless life without any diet restriction. I would definitely recommend this treatment to other Cancer sufferer.
Note: Result varies from patient to patient. These testimonials do not constitute typical results nor do we claim otherwise.
GIOSTAR CEO Mr. Deven Patel on The Silver Hair Tsunami TV show
Dear Dr. Srivastava,
It is a pleasure to welcome you to the Editorial Board. Attached is the confirmation letter for your record. We would like to request you to send us your CV for our record. We also updated your information on the journal webpage at following link:
Once we receive any manuscript in your area of expertise, we will send you a request for editorial handling and review. We greatly appreciate any contributions or feedback.
Please do not hesitate to contact us if you have any questions.
Kanako Nishino – Publishing Assistant
Editorial Office – Journal of Embryology & Developmental Biology
JSciMed Central, 1455 Frazee Road, Suite 500 (Office 570), San Diego, California 92108, USA
Direct Tel: 1-619-940-8643
Toll free number: 1-888-572-4633 (1-888-JSCIMED)
Journal Email: email@example.com
Dear Dr. Srivastava,
We are currently accepting submissions for our upcoming Special Issue titled “Cytoprotective Mediators and Signaling Pathways in Cardiovascular Stem Cell Therapy,” which will be published in Stem Cells International in January 2017. The Special Issue is open to both original research articles and review articles, and the deadline for submission is August 19, 2016. You can find the Call for Papers at http://www.hindawi.com/journals/sci/si/353148/cfp/.
The most recent Impact Factor for Stem Cells International is 3.687 according to Thomson Reuters’ latest Journal Citation Reports. The journal is a peer-reviewed, open-access publication, which means that all published articles are made freely available online at http://www.hindawi.com/journals/sci/ without a subscription and authors retain the copyright of their work. Moreover, all published articles will be made available on PubMed Central and indexed in PubMed at the time of publication.
Please read over the journal’s author guidelines at http://www.hindawi.com/journals/sci/guidelines/ for more information on the journal’s policies and the submission process. Manuscripts should be submitted online to the Special Issue at http://mts.hindawi.com/submit/journals/sci/psps/.
Please do not hesitate to contact me if you have any questions.
Stem Cells International
Hindawi Publishing Corporation